Consistently, treatment of experimental ligature-induced periodontitis by systemic administration of the humanized monoclonal IL-6R antibody tocilizumab suppressed inflammatory cell recruitment, Th17 cytokines and impaired RANKL expression. This evidence concerns the gene TNFSF11 and periodontitis.